In the previous studies, we compared the PPARγ, PPARGC1A, and PPARGC1B SNVs with susceptibility of esophageal, colorectal, and hepatocellular carcinomas [31–33]. This evidence concerns the gene PPARGC1A and hepatocellular carcinoma.